Stephen Hoge Moderna, Inc. (MRNA) insider trading activity

Stephen Hoge is President of Moderna, Inc.. Currently has a direct ownership of 1.44 Million shares of MRNA, which is worth approximately $53.2 Million. The most recent transaction as insider was on Feb 23, 2021, when has been sold 15,000 shares (Common Stock) at a price of $144.09 per share, resulting in proceeds of $2,161,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.44M

0.06% 3M change

8.33% 12M change

Total Value Held $53.2 Million

Stephen Hoge Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 23 2021	SELL Open market or private sale	$2,161,350 $144.09 p/Share	15,000 Reduced 0.92%	1,614,597 Common Stock
Feb 23 2021	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.61%	1,629,597 Common Stock
Feb 16 2021	SELL Open market or private sale	$2,742,000 $182.8 p/Share	15,000 Reduced 0.92%	1,619,597 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.61%	1,634,597 Common Stock
Feb 12 2021	SELL Open market or private sale	$925,000 $185.0 p/Share	5,000 Reduced 0.31%	1,624,597 Common Stock
Feb 03 2021	SELL Open market or private sale	$1,565,100 $156.51 p/Share	10,000 Reduced 0.61%	1,629,597 Common Stock
Feb 03 2021	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.61%	1,639,597 Common Stock
Feb 02 2021	SELL Open market or private sale	$1,584,000 $158.4 p/Share	10,000 Reduced 0.61%	1,629,597 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.61%	1,639,597 Common Stock
Jan 25 2021	SELL Open market or private sale	$2,859,400 $142.97 p/Share	20,000 Reduced 1.21%	1,629,597 Common Stock
Jan 25 2021	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.6%	1,649,597 Common Stock
Jan 24 2021	SELL Open market or private sale	$1,365,050 $273.01 p/Share	5,000 Reduced 0.31%	1,609,597 Common Stock
Jan 24 2021	BUY Exercise of conversion of derivative security	$54,500 $10.9 p/Share	5,000 Added 0.31%	1,614,597 Common Stock
Jan 13 2021	SELL Open market or private sale	$1,855,500 $123.7 p/Share	15,000 Reduced 0.91%	1,639,597 Common Stock
Jan 13 2021	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.6%	1,654,597 Common Stock
Jan 12 2021	SELL Open market or private sale	$587,500 $117.5 p/Share	5,000 Reduced 0.3%	1,644,597 Common Stock
Jan 04 2021	SELL Open market or private sale	$2,143,000 $107.15 p/Share	20,000 Reduced 1.2%	1,649,597 Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	$19,800 $0.99 p/Share	20,000 Added 1.18%	1,669,597 Common Stock
Dec 29 2020	SELL Bona fide gift	-	70,000 Reduced 4.07%	1,649,597 Common Stock
Dec 24 2020	SELL Open market or private sale	$627,950 $125.59 p/Share	5,000 Reduced 0.29%	1,719,597 Common Stock
Dec 23 2020	SELL Open market or private sale	$1,235,500 $123.55 p/Share	10,000 Reduced 0.58%	1,724,597 Common Stock
Dec 23 2020	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.57%	1,734,597 Common Stock
Dec 14 2020	SELL Open market or private sale	$3,272,600 $163.63 p/Share	20,000 Reduced 1.15%	1,724,597 Common Stock
Dec 14 2020	BUY Exercise of conversion of derivative security	$9,900 $0.99 p/Share	10,000 Added 0.57%	1,744,597 Common Stock
Dec 03 2020	SELL Open market or private sale	$1,435,900 $143.59 p/Share	10,000 Reduced 0.57%	1,734,597 Common Stock

Also insider at

AXLA

Axcella Health Inc. Healthcare

Director

Stephen Hoge

President

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account